Hibiotic N 600 mg/5 mI Powder for suspension preparation 80 ml
92£
View analogs- Treatment of infectious and inflammatory diseases caused by susceptible pathogens:
- Upper respiratory tract and ENT infections (otitis media, sinusitis, tonsillitis).
- Lower respiratory tract infections (acute and chronic bronchitis, pneumonia, lung abscess, pleural empyema).
- Urinary tract and pelvic infections (pyelonephritis, cystitis, urethritis, prostatitis, endometritis, gonorrhea).
- Skin and soft tissue infections (erysipelas, impetigo, abscesses, cellulitis, wound infections).
- Bone and joint infections (osteomyelitis).
- Surgical infection prophylaxis and post-operative wound infections.
Buy
Product quantities
Form of Release: Powder
Product Brand:
Amoun Pharmaceutical Co.S.A.E
About the brand
Product Categories: Antibiotics • Antibiotics for tonsillitis • Antibiotics for bronchitis • Antibiotics for sinusitis • Broad spectrum antibiotics
Hibiotic N 600 mg/5 mI Powder for suspension preparation 80 ml
Composition:
Active Ingredients:
Each 5 mL of reconstituted suspension contains
Amoxicillin (as trihydrate) 600 mg and Clavulanic Acid (as potassium clavulanate) 42.9 mg.
Excipients:
Trisodium citrate, citric acid, aerosil 200 (colloidal silicon dioxide), avicel (microcrystalline cellulose), dimethicone, lemon flavor, sucrose.
Product Description:
- Hibiotic N is a broad-spectrum antibacterial combination consisting of amoxicillin (a semi-synthetic penicillin) and clavulanic acid (a beta-lactamase inhibitor).
- Amoxicillin destroys bacteria by inhibiting bacterial cell wall synthesis.
Clavulanic acid protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending the antibacterial spectrum. - It is active against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria (including Staphylococcus, Streptococcus, Haemophilus influenzae, Streptococcus pneumoniae, Escherichia coli, and Klebsiella species).
Indications for Use:
- Treatment of infectious and inflammatory diseases caused by susceptible pathogens:
- Upper respiratory tract and ENT infections (otitis media, sinusitis, tonsillitis).
- Lower respiratory tract infections (acute and chronic bronchitis, pneumonia, lung abscess, pleural empyema).
- Urinary tract and pelvic infections (pyelonephritis, cystitis, urethritis, prostatitis, endometritis, gonorrhea).
- Skin and soft tissue infections (erysipelas, impetigo, abscesses, cellulitis, wound infections).
- Bone and joint infections (osteomyelitis).
- Surgical infection prophylaxis and post-operative wound infections.
Method of Administration and Dosage:
- Administered orally.
- To reduce potential gastrointestinal discomfort and optimize absorption, take Hibiotic N at the start of a meal.
- Dosage is determined individually based on age, body weight, renal function, and severity of the infection.
- Children aged 3 months and older (twice daily, every 12 hours):
Body weight 8 kg: 3.0 mL.
Body weight 12 kg: 4.5 mL.
Body weight 16 kg: 6.0 mL.
Body weight 20 kg: 7.5 mL.
Body weight 24 kg: 9.0 mL.
Body weight 28 kg: 10.5 mL.
Body weight 32 kg: 12.0 mL.
Body weight 36 kg: 13.5 mL. - Lower doses are used for mild skin/soft tissue infections and recurrent tonsillitis; higher doses are recommended for otitis media, sinusitis, lower respiratory, and bone/joint infections.
- Treatment duration: Minimum course is 5 days.
- Treatment should not exceed 14 days without clinical re-evaluation.
Contraindications:
- Known hypersensitivity or allergic reaction to amoxicillin, clavulanic acid, penicillins, cephalosporins, or other beta-lactam antibiotics.
- Infectious mononucleosis (high risk of developing a maculopapular rash).
- Phenylketonuria.
- History of amoxicillin/clavulanic acid-associated jaundice or hepatic dysfunction.
- Severe renal impairment (creatinine clearance less than 30 mL/min).
Precautions:
- Use with caution in patients with severe hepatic impairment, chronic renal failure, or gastrointestinal disease (including antibiotic-associated colitis history).
- Perform periodic monitoring of hepatic, renal, and hematopoietic functions during prolonged therapy.
- Cross-reactivity may occur in patients with known hypersensitivity to penicillins or cephalosporins.
- Discontinue treatment immediately if an allergic reaction occurs.
- May cause false-positive results in urine glucose tests (enzymatic glucose oxidase methods are recommended).
Adverse Reactions / Side Effects:
- Gastrointestinal System: Common: nausea, vomiting, diarrhea; Rare: stomatitis, gastritis, elevated liver enzymes; Very rare: cholestatic jaundice, hepatitis, pseudomembranous colitis, tooth discoloration.
- Allergic Reactions: Urticaria, skin rash, itching; Rare: angioedema, anaphylaxis, erythema multiforme, Stevens-Johnson syndrome.
- Hematopoietic System: Reversible leukopenia, thrombocytopenia, hemolytic anemia, prolonged bleeding time.
- Nervous System: Dizziness, headache, hyperactivity, anxiety, seizures (with high doses or renal impairment).
- General: Fungal overgrowth (candidiasis/thrush), crystalluria, interstitial nephritis.
Pregnancy and Lactation:
Use during pregnancy and breastfeeding should be avoided unless clearly necessary and prescribed by a physician, evaluating potential maternal benefit against fetal/infant risk.
Storage Conditions:
- Dry Powder:
Store at a temperature not exceeding 25 °C in a dry place protected from light. - Reconstituted Suspension:
Store in a refrigerator (at 2–8 °C) and use within 7 days. - Do not freeze.
- Keep out of reach of children.
Packaging:
Cardboard box containing a bottle with 53.4 g of powder to prepare 80 mL of oral suspension, a measuring spoon/syringe, and a patient information leaflet.
Tags, Keywords:
Active Ingredients:
No comments yet. Be the first to write one.
Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.
Русский
English
عربي


